Influence of the tryptophan-indole-IFNÎ³ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections by Ashok Aiyar et al.
HYPOTHESIS AND THEORY ARTICLE
published: 03 June 2014
doi: 10.3389/fcimb.2014.00072
Influence of the tryptophan-indole-IFNγ axis on human
genital Chlamydia trachomatis infection: role of vaginal
co-infections
Ashok Aiyar1*, Alison J. Quayle1, Lyndsey R. Buckner1, Shardulendra P. Sherchand1,
Theresa L. Chang2, Arnold H. Zea1, David H. Martin3 and Robert J. Belland4
1 Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
2 Department of Microbiology and Molecular Genetics, Public Health Research Institute Center, New Jersey Medical School—Rutgers, The State University of
New Jersey, Newark, NJ, USA
3 Section of Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA
4 Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Sciences Center, Memphis, TN, USA
Edited by:
Robert V. Schoborg, East Tennessee
State University, USA
Reviewed by:
Scott Grieshaber, University of
Florida, USA
Ted Hackstadt, Rocky Mountain
Laboratories/NIAID/NIH, USA
Ian Clarke, University of
Southampton, UK
*Correspondence:
Ashok Aiyar, Department of
Microbiology, Immunology, and
Parasitology, Louisiana State
University Health Sciences Center,
Medical Education Building, 1901
Perdido Street, New Orleans, LA
70112, USA
e-mail: aaiyar@lsuhsc.edu
The natural history of genital Chlamydia trachomatis infections can vary widely; infections
can spontaneously resolve but can also last from months to years, potentially progressing
to cause significant pathology. The host and bacterial factors underlying this wide
variation are not completely understood, but emphasize the bacterium’s capacity to
evade/adapt to the genital immune response, and/or exploit local environmental conditions
to survive this immune response. IFNγ is considered to be a primary host protective
cytokine against endocervical C. trachomatis infections. IFNγ acts by inducing the host
enzyme indoleamine 2,3-dioxgenase, which catabolizes tryptophan, thereby depriving the
bacterium of this essential amino acid. In vitro studies have revealed that tryptophan
deprivation causes Chlamydia to enter a viable but non-infectious growth pattern that
is termed a persistent growth form, characterized by a unique morphology and gene
expression pattern. Provision of tryptophan can reactivate the bacterium to the normal
developmental cycle. There is a significant difference in the capacity of ocular and genital
C. trachomatis serovars to counter tryptophan deprivation. The latter uniquely encode
a functional tryptophan synthase to synthesize tryptophan via indole salvage, should
indole be available in the infection microenvironment. In vitro studies have confirmed
the capacity of indole to mitigate the effects of IFNγ; it has been suggested that a
perturbed vaginal microbiome may provide a source of indole in vivo. Consistent with
this hypothesis, the microbiome associated with bacterial vaginosis includes species
that encode a tryptophanase to produce indole. In this review, we discuss the natural
history of genital chlamydial infections, morphological and molecular changes imposed by
IFNγ on Chlamydia, and finally, the microenvironmental conditions associated with vaginal
co-infections that can ameliorate the effects of IFNγ on C. trachomatis.
Keywords: Chlamydia trachomatis, IFNγ, IDO1, tryptophan, persistence, indole, bacterial vaginosis, vaginal
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INTRODUCTION
Chlamydia trachomatis is an obligate intracellular bacterium
that has a unique biphasic developmental cycle. C. trachomatis
serovars D through K are tropic for columnar epithelial cells of
the urogenital tract; the endocervix is the most common site of
infection in women, but organisms can ascend into the uterus
and Fallopian tubes where they can cause pelvic inflammatory
disease (PID) and the longer-term sequelae of tubal infertility
and ectopic pregnancy. Infected, untreated women can also ver-
tically transmit their infection to neonates, with consequences
including pneumonia. Additionally, infected women have a sig-
nificantly increased risk of acquiring, shedding and/or trans-
mitting, human immunodeficiency virus-1 (HIV-1) (Wasserheit,
1992; Ghys et al., 1997; Fleming and Wasserheit, 1999; Chesson
and Pinkerton, 2000; Farley et al., 2003). Despite extensive public
health interventions including education, screening, and antibi-
otic treatment, C. trachomatis infections remain a significant
global health problem, with reported U.S. cases reaching 1million
in 2006 and continuing to rise since (Centers for Disease Control,
2011). This burden of cases, together with the predominantly
asymptomatic nature of the disease, have led the C. trachomatis
infection to be called the “silent epidemic” (Wallis, 2001). The
development of a vaccine is now considered a priori in the control
of this infection.
The natural history of genital C. trachomatis infection can vary
considerably. Untreated infections can be asymptomatic for sub-
stantial periods of time, progress to cause significant pathology, or
spontaneously resolve without antibiotic treatment (Parks et al.,
1997; Golden et al., 2000; Joyner et al., 2002; Morre et al., 2002;
Molano et al., 2005; Geisler, 2010; Centers for Disease Control,
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2011). It is not understood why some C. trachomatis infections
can last from months to years; clearly, the organism has the
ability to survive by exploiting, adapting to, or evading, certain
genital immune and environmental conditions (Brunham and
Rey-Ladino, 2005). Establishing the local genital environments
that enable, enhance, or deterC. trachomatis survival should allow
us to: (a) identify the women at risk for extended infections;
(b) define the conditions needed for the genital immune system
to resolve infection naturally, and (c) aid in designing targeted
vaccination and therapeutic strategies. Pertinent to this, C. tra-
chomatis is a tryptophan auxotroph; therefore, induction of the
tryptophan-catabolizing enzyme, indoleamine-2,3-dioxygenase
1 (IDO1), by the cytokine interferon gamma (IFNγ) restricts
chlamydial growth and development in human epithelial cells
(Shemer and Sarov, 1985; Byrne et al., 1986, 1989; Carlin et al.,
1989; Beatty et al., 1994a; Brunham and Rey-Ladino, 2005). For
this reason, IFNγ is considered to be a major anti-chlamydial
effector cytokine. In vitro, exposure of C. trachomatis-infected
epithelial cells to IFNγ can result in bacterial death, or, can cause
the organism to adopt a viable but non-infectious growth mode
that is termed a persistent or abnormal growth form (reviewed
by Wyrick, 2010). In vitro, dependent on the culture conditions,
persistent growth forms can proceed to clearance upon prolonged
starvation, or they can reactivate and replicate to produce infec-
tious elementary bodies (EBs) (Byrne et al., 1986, 1989; Beatty
et al., 1993, 1994a). Pertinent to IFNγ-induced tryptophan star-
vation, genital, but not ocular, serovars of C. trachomatis have
retained a functional tryptophan synthase that enables them to
synthesize tryptophan via indole salvage (Fehlner-Gardiner et al.,
2002; Caldwell et al., 2003). Thus, if indole is present at a suf-
ficient concentration in the infection microenvironment, genital
serovars could circumvent the bactericidal/bacteriostatic effects of
IFNγ (Beatty et al., 1993; Fehlner-Gardiner et al., 2002; Belland
et al., 2003; Caldwell et al., 2003). This suggests the capacity to
synthesize tryptophan in an IFNγ-rich infection microenviron-
ment is an important virulence factor for genital C. trachomatis
serovars. In vivo, the source of indole in the infection microenvi-
ronment remains unknown. However, perturbations in the vagi-
nal flora that increase the prevalence of indole-producing bacteria
during bacterial vaginosis (BV) may increase the susceptibility of
women to extended infections even in the face of a robust IFNγ
response, a hypothesis originally proposed by Caldwell and co-
workers in a seminal Journal of Clinical Investigation study in
2003 (Caldwell et al., 2003). However, until recent work by others
and us, the nature of a “real” clinical infection, the in vivo growth
characteristics of C. trachomatis, and the composition of the
genital milieu in vivo have remained almost completely unchar-
acterized, precluding a test of this hypothesis. The purpose of this
review is to: (a) describe the recent advances made in the char-
acterization of the normal and perturbed vaginal microbiome
that are pertinent to the indole-rescue hypothesis; (b) describe
recent in vivo data to support and extend this hypothesis, includ-
ing evidence that C. trachomatis can adopt a persistent growth
mode in vivo, and that BV provides an indole-rich genital envi-
ronment; and (c) explicate the mechanism by which BV and/or
the vaginal Trichomonas vaginalis (TV) co-infections could mod-
ulate the effect of IFNγ on C. trachomatis growth and clearance
in vivo, including ramifications on clinical outcomes and choice
of treatment.
IFNγ-MEDIATED IMMUNITY TO GENITAL C. TRACHOMATIS
INFECTION
Several lines of evidence indicate genital C. trachomatis infec-
tion induces human immunity and that this immunity is variably
protective, as reviewed recently (Batteiger et al., 2010). These
include: (a) young age as a significant risk factor for infection
acquisition (Arno et al., 1994); (b) reduced organism load with
repeat infections (Barnes et al., 1990); (c) natural history stud-
ies documenting spontaneous resolution of infection (Parks et al.,
1997; Golden et al., 2000; Joyner et al., 2002; Morre et al., 2002;
Molano et al., 2005; Centers for Disease Control, 2010; Geisler,
2010); and (d) association of spontaneous resolution of infec-
tion with subsequent protection from incident disease (Geisler
et al., 2013). Immunity in humans appears to develop slowly
and protection from infection is generally thought to be robust
only after multiple exposures and can be as short as several
months (Katz et al., 1987; Molano et al., 2005), a finding cor-
roborated in animal models (Rank andWhittum-Hudson, 2010).
Further, chronic infection has been associated with pathology
and the long-term sequelae of disease. Thus, significant current
declines in PID are attributed to the aggressive “seek and treat”
public health intervention strategies that are now in place in
many developed countries (Brunham and Rekart, 2008, 2009).
Paradoxically, this strategy has also been partially attributed to
increasing rates of disease by blunting the development of pro-
tective immunity to this pathogen, thereby increasing the sus-
ceptibility of the population to disease (Brunham and Rekart,
2008). This has been termed the “arrested immunity” hypothe-
sis and is corroborated by antibiotic intervention studies in mice
(Su et al., 1999). Finally, in studies of sex workers who have
a high risk of exposure to C. trachomatis via C. trachomatis-
infected clients, the probability of incident C. trachomatis infec-
tion correlates inversely with duration of prostitution (Brunham
et al., 1996). Finally, immune dysfunction, as indicated by HIV
seropositive status, is a risk factor for incident C. trachomatis
infection (ibid).
Evidence for an association of IFNγ with genital chlamydial
infection is supported by multiple experimental studies in ani-
mals (reviewed in detail in Rank and Whittum-Hudson, 2010)
and observational/correlative studies in humans. Pertinently, in
the murine model of genital infection using Chlamydia muri-
darum, a species that shares substantial genomic synteny with
C. trachomatis, T-cells and IFNγ are critical to the resolution
of, and subsequent protection from, genital infection (Ramsey
et al., 1988; Cain and Rank, 1995; Su et al., 1997; Johansson and
Lycke, 2001). Thus, CD4, MHC class II, IFNγ and IFNγ-receptor
depletion/knockout results in chronic infection, uncontrolled C.
muridarum bacterial burden and/or lack of protection from re-
infection (Cotter et al., 1997; Perry et al., 1997; Morrison et al.,
2000; Li et al., 2008; Jupelli et al., 2010; Andrew et al., 2013).
Interestingly, IDO1 is poorly induced by IFNγ in murine epithe-
lial cells, and is not required for resolution of genital C. muri-
darum infection (McClarty et al., 2007). Rather, mice restrict C.
muridarum though a cell-autonomous resistance mechanism by a
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large family of IFNγ-inducible GTPases called immunity related
GTPases (Nelson et al., 2005; Miyairi et al., 2007; Coers et al.,
2008; Burian et al., 2010). Consistent with the molecular mech-
anisms underlying IFNγ-mediated restriction in mice differing
from those operant in humans, subsequent elegant molecular and
cross-species studies indicate the genes that are divergent in C.
muridarum and C. trachomatis strongly correlate with the ability
to evade species-specific IFNγ effector activities. Similarly com-
parisons of genital and ocular C. trachomatis serovars indicate a
strong correlation with evasion of tissue-specific IFNγ effector
activities (Morrison, 2003).
In human genital infections, local cervical T-cell infiltrates
and genital IFNγ concentrations are significantly elevated dur-
ing active infection, higher in women with recurrent vs. primary
infection, and decreased upon resolution of infection (Figure 1),
and (Arno et al., 1990; Loomis and Starnbach, 2002; Agrawal
et al., 2007; Ficarra et al., 2008; Sperling et al., 2013). Local IFNγ-
producing C. trachomatis-specific CD4 T-cells are found in the
endometrium of women with a high risk of exposure to C. tra-
chomatis (Ondondo et al., 2009). Systemically, anti-chlamydial
IFNγ-producing T-cells generally peak 1–2 months after active
infection in most antibiotic-treated women (Vicetti et al., 2012);
however, in highly-exposed women, IFNγ-producing T-cells that
recognize epitopes from C. trachomatis HSP60 correlate with
protection against incident C. trachomatis (Cohen et al., 2005).
Finally, in highly exposed HIV seropositive women, a low CD4
count is associated with low C. trachomatis-induced IFNγ pro-
duction (Cohen et al., 2000), and increased the risk of infection
spread to the upper reproductive tract and PID (Kimani et al.,
FIGURE 1 | IFNγ levels in paired endocervical secretion samples from
women during, and post-antibiotic resolution, of C. trachomatis
infection. Endocervical secretions, harvested as previously described
(Gumbi et al., 2008), were collected from 11 women during an ongoing
NAAT+ C. trachomatis infection, and again 3–6 weeks after azithromycin
treatment and a confirmed NAAT− C. trachomatis test. Samples were
quantified using multiplex cytokine analysis (Millipore), and comparisons
between infected and non-infected states investigated by a
Wilcoxon-Mann-Whitney test. A p-value of < 0.05 was considered
significant. CT+ indicates samples from patients with an active infection
and FU indicates post-antibiotic follow-up samples.
1996). While human research is challenging, we believe that new
studies and tools are critical to further delineate, and mecha-
nistically dissect, the complex relationships that exist between
host immunity and bacteria in the context of the local genital
environment.
THE HUMAN EPITHELIAL CELL AND C. TRACHOMATIS
RESPONSE TO IFNγ AND DEPLETION OF TRYPTOPHAN
Because C. trachomatis is a tryptophan auxotroph, IDO1-
mediated depletion of tryptophan curtails its growth (Taylor and
Feng, 1991; Beatty et al., 1994a). C. trachomatis development is
initiated when an infectious, but largely metabolically inactive, EB
attaches to and enters the host cell. The internalized EB differen-
tiates and replicates by binary fission as reticulate bodies (RBs)
within a cytoplasmic membrane-bound inclusion. The comple-
tion of the developmental cycle is marked by re-differentiation
of RBs into EBs that egress from the host cell. However, under
conditions of limited tryptophan availability, the developmental
cycle is arrested in the RB stage in a manner that results in mor-
phologically distinct, large aberrant, viable but non-cultivable,
persistent growth forms (Beatty et al., 1994a). Restoration of tryp-
tophan availability can reactivate these persistent forms to return
to normal development (Byrne et al., 1986). Similarly, provision
of indole can reactivate persistent forms from genital, but not
ocular, serovars, because the former synthesize a functional tryp-
tophan synthase in response to tryptophan starvation (Caldwell
et al., 2003).
CHLAMYDIAL GENE EXPRESSION PATTERNS INDUCED
BY IFNγ
The induction of persistent forms with IFNγ, and their subse-
quent reactivation, have been studied in vitro through microar-
ray analysis. Persistent growth, characterized by large aberrant
RBs, led to the up-regulation of genes involved in tryptophan
utilization, DNA repair and recombination, phospholipid biosyn-
thesis and translation. Up-regulation of the repressible trpBA
operon (Belland et al., 2003) confirms the previous observa-
tions that IFNγ treatment reduces intracellular concentrations
of tryptophan. In addition, a number of early genes were up-
regulated, particularly the euo gene (30-fold increase), which
encodes a DNA-binding protein that has been shown to bind to
a late gene promoter region (i.e., omcAB Zhang et al., 1998) to
repress expression. Euo has been shown to down-regulate mul-
tiple late genes (Rosario and Tan, 2012); down-regulation of C.
trachomatis genes involved in RB to EB differentiation, proteol-
ysis and peptide transport, and cell division were seen during
persistent growth induced by IFNγ. These transcriptional anal-
yses were consistent with the biological properties associated
with aberrant RBs in that the RBs were blocked in cytokinesis,
and the developmental cycle was arrested at a point preceding
late gene expression. Indeed, EM analyses of persistent forms
induced by IFNγ treatment, indicates that large aberrant RBs
are arrested in cytokinesis. This morphology appears to con-
trast quite strikingly with persistent forms induced by exposure
to penicillins or the danger signal adenosine (Pettengill et al.,
2009; Skilton et al., 2009), but resemble the atypical forms
observed previously upon IFNγ treatment (Beatty et al., 1993,
1994b).
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Recently, we have developed protocols that allowed the parallel
assessment of both C. trachomatis gene transcription (specifically
the euo:omcB ratio), and ultrastructure of C. trachomatis growth
forms found in vivo in human endocervical infection (Lewis et al.,
2014). The sampling protocols also permitted the quantification
of indole and IFNγ levels from the same environment (ibid).
Using this multi-parameter sampling approach, we were able to
visualize two strikingly different growth patterns ofC. trachomatis
growth in two patients. Specifically, one infection was character-
ized by morphologically normal late-stage inclusions, high viable
bacterial numbers, and a low euo:omcB mRNA expression pro-
file, together with the presence of a high concentration of indole
and no IFNγ. In contrast, the second infection included mor-
phologically aberrant forms similar in ultrastructure to in vitro
persistence induced by IFNγ, a high euo:omcB mRNA expres-
sion profile, low infectious titer, and large bacterial DNA load
together with a local IFNγ response. This approach, that may
be expanded to include an even more detailed analysis of C. tra-
chomatis and host gene expression, indicate the distinct possibility
of understanding how C. trachomatis grows in the genital tract,
along with the environmental stresses, including IFNγ, which it
encounters.
TRYPTOPHAN SUPPLEMENTATION REVERSES
TRANSCRIPTIONAL CHANGES INDUCED BY IFNγ
In the in vitro model of IFNγ-induced persistence, removal of
IFNγ and supplementation with added tryptophan led to a rapid
reactivation from persistent growth (Belland et al., 2003). During
reactivation the expression differences rapidly returned to con-
trol levels, i.e., euo expression dropped 20-fold in 12 h. The
transcriptional changes in the presence of IFNγ that result in per-
sistent growth appear to constitute a persistence stimulon. Thus,
we earlier postulated that this coordinated biological response
is speculated to have evolved to allow the organism to rapidly
respond to immunological pressure in a manner that allows for
a period of resistance followed by rapid recovery after the waning
of the host response.
GENITAL SEROVARS OF C. TRACHOMATIS CAN SYNTHESIZE
A FUNCTIONAL TRYPTOPHAN SYNTHASE
Shaw et al, who reported that ocular serovars encoded a truncated
TrpA protein (Shaw et al., 2000), initially described differences
in tryptophan synthase between ocular and genital serovars of
C. trachomatis. This analysis was extended by Fehlner-Gardiner
et al., who reported that genital, but not ocular, C. trachoma-
tis serovars encode a functional, tightly regulated, tryptophan
synthase (trpBA) permitting the bacteria to synthesize trypto-
phan from indole (Fehlner-Gardiner et al., 2002; Akers and Tan,
2006; Carlson et al., 2006). Along with other genes that affect
pathogenesis and distinguish ocular and genital serovars of C. tra-
chomatis (Carlson et al., 2004; Nelson et al., 2006; Taylor et al.,
2010), the enzymes required for the biosynthesis of tryptophan
are also encoded by genes within the plasticity zone (McClarty
et al., 2007). The complement of trp genes within this region
varies between chlamydial species. C. pneumoniae and C. muri-
darum do not encode trp genes (Xie et al., 2002a). C. psittaci
lacks the trpE gene and is therefore incapable of synthesizing
the anthranilate, an essential precursor for tryptophan biosyn-
thesis. C. trachomatis urogenital isolates only have a subset of trp
genes, encoded in the plasticity zone: trpR, encoding a trp repres-
sor; and trpA and trpB, encoding homologs of the α (TrpA) and
β (TrpB) subunits of tryptophan synthase. As reviewed recently
(Raboni et al., 2009; Miles, 2013), tryptophan synthase is a
tetramer consisting of two α subunits and two β subunits (α2β2).
Functional and sequence analyses indicate that in most bacte-
rial species that express a α2β2 tetramer, the enzyme is predicted
to be bi-functional and catalyze the cleavage of indole glycerol-
3-phosphate (IGP) to indole and glyceraldehyde-3-phosphate
(TrpA catalyzed α reaction), followed by the reaction of indole
with serine to form tryptophan (TrpB catalyzed β-replacement
reaction) (Xie et al., 2002b; Raboni et al., 2009; Miles, 2013).
However, sequence analysis, and complementation studies con-
ducted in E. coli, together indicate that the TrpA subunit in C.
trachomatis appears to function structurally but not enzymat-
ically (Fehlner-Gardiner et al., 2002; Xie et al., 2002b). As a
consequence, the TrpA/TrpB tetramer expressed by C. trachoma-
tis during tryptophan starvation cannot use IGP as a substrate
for tryptophan biosynthesis; rather, it requires indole (Fehlner-
Gardiner et al., 2002). Therefore, indole, and not IGP, may
be an important molecule in chlamydial growth by modulat-
ing the effectiveness of the IFNγ response in bacterial clearance.
Subsequent studies by Caldwell et al. verified the absolute cor-
relation between tissue tropism and trpBA expression in >200
clinical isolates (Caldwell et al., 2003). All urogenital isolates had
an intact trpRBA operon, while >90 ocular isolates invariably
had frame-shift-inducing deletions within the trpA or trpB genes
or had deleted the entire operon (ibid). This provided a molec-
ular basis for the observation that only genital isolates could
synthesize tryptophan from indole. While the enzymatic capac-
ity of the chlamydial tryptophan synthase to salvage indole has
been assessed only in E. coli, pioneering genetic studies reveal
that a C. trachomatis null mutant in trpB has lost the capacity
to escape IFNγ-mediated tryptophan depletion via indole salvage
(Kari et al., 2011). Together, these data reveal a strong selective
pressure for genital C. trachomatis strains to use indole salvage as
a mechanism to escape IFNγ-mediated eradication by the host.
Therefore, the ability to overcome tryptophan starvation may
provide a mechanism through which C. trachomatis could cause
extended and chronic infections in some women despite a robust
induction of IFNγ. Critically, the availability of indole within the
infection microenvironment is predicted to modulate the effect
of IFNγ. Genital chlamydial infections occur in the context of
the genital microbiome, of which the vaginal microbiome has
been characterized in depth. The vaginal microbiome, particu-
larly when perturbed, has been postulated to be the source of
indole (Caldwell et al., 2003).
AN INDOLE-POOR OCULAR MICROENVIRONMENT MAY
SELECT AGAINST A FUNCTIONAL TRYPTOPHAN SYNTHASE
Although not the focus of this review, the stark contrast in
the ability of urogenital and ocular C. trachomatis isolates to
express a functional tryptophan synthase is intriguing to us.
Unlike the vaginal microbiome, which as described below has
been characterized under a variety of conditions, the normal
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ocular microbiome is far less characterized. The two most promi-
nent phyla in the ocular microbiome from four healthy subjects
were Pseudomonas and Bradyrhizobium, neither of which produce
indole (Dong et al., 2011). We note that the absence of indole
in the conjunctival microenvironment is insufficient to explain
why ocular chlamydial isolates have uniformly lost the capac-
ity to express a functional tryptophan synthase, most often as a
consequence of point mutations. This apparent negative selec-
tion may result from an alternative enzymatic reaction catalyzed
by tryptophan synthase when indole is absent; specifically, the
β-elimination reaction in which L-serine is deaminated to pro-
duce pyruvate and ammonia (Kumagai and Miles, 1971; Miles
and McPhie, 1974; Xie et al., 2002b; Raboni et al., 2009). While
initially described as a function of β2 dimers, detailed studies
examining the functions of the α2β2 tetrameric enzyme from S.
typhimurium have revealed that it also catalyzes the β-elimination
reaction necessary to produce ammonia (Ahmed et al., 1991;
Raboni et al., 2005). While this catalysis is allosterically curtailed
in the tetrameric enzyme by the glyceraldehyde-3-phosphate
product of the α reaction, the C. trachomatis TrpA sequence, and
functional analyses, indicate that it cannot bind IGP and catalyze
the α reaction (Fehlner-Gardiner et al., 2002; Xie et al., 2002b).
Further, sequence changes in the loop 6 of the C. trachomatis
α subunit are predicted to prevent the inter-subunit interac-
tions necessary for allosteric control (Schneider et al., 1998),
consistent with the outcome of mutational analyses of the S.
typhimurium enzyme (Yang and Miles, 1992; Brzovic et al., 1993;
Kulik et al., 2002; Raboni et al., 2005). Pertinently, the active-
site residues necessary for β-elimination catalysis to produce
ammonia remain highly conserved in TrpB from C. trachoma-
tis. Therefore, the α2β2 tetrameric enzyme from C. trachomatis
is predicted to catalyze the generation of ammonia from serine
when indole is absent. In addition to its anti-microbial effects
(Rideal, 1895), ammonia is also known to induce apoptosis of
epithelial cells that express the NMDA receptor (Suzuki et al.,
2002; Sachs et al., 2011). In this context, the production of ammo-
nia is currently proposed to underlie apoptosis of gastric epithelial
cells induced by H. pylori (Seo et al., 2011). It may be of rele-
vance that although their expression in the normal conjunctiva
has not been examined, NMDA receptors are expressed in some
ocular epithelial cell-lines (Oswald et al., 2012). As reviewed
recently, cellular infiltrates associated with human conjuncti-
val C. trachomatis infections include T-cells, which are capable
of producing IFNγ (Hu et al., 2013). The consequential IFNγ-
induced expression of a functional tryptophan synthase in an
indole-limiting environment is predicted to generate ammonia by
deaminating serine, with ensuing effects that may directly select
against bacterial replication or cause apoptosis of infected cells
prior to completion of the normal C. trachomatis developmental
cycle.
Regardless of the pressure against the expression of a func-
tional tryptophan synthase in trachoma, the strong selective
pressure on urogenital isolates to retain the capacity to synthe-
size tryptophan via indole salvage is striking. It is likely this
pressure reflects the influence of the urogenital microbiome on
C. trachomatis replication in the face of a protective immune
response.
THE VAGINAL MICROBIOME AND ITS EFFECTS
It is now well appreciated that the vaginal microbiome can sig-
nificantly impact the reproductive health of women, their fetuses
and their newborns (Hillier et al., 1995; Zhou et al., 2010; Ma
et al., 2012). Bacterial vaginosis (BV), which affects 29% of
reproductive age women in the US, is characterized by the loss
of Lactobacillus species and a concomitant overgrowth of diverse
anaerobes (Koumans et al., 2001, 2007). BV can be diagnosed
by a gram stain-based scoring system termed the Nugent score
and is calculated by assessing for the presence of large Gram-
positive rods (chiefly Lactobacillus species), small Gram-variable
rods and curved gram-variable rods; scores range from 1–10 and
a Nugent of 7–10 is considered a diagnosis of BV and repre-
sents a sharp decrease in the number of Gram-positive rods with
a simultaneous increase in the latter two morphotypes (Nugent
et al., 1991; Delaney and Onderdonk, 2001). BV increases sus-
ceptibility to various STDs and PID (Haggerty et al., 2004) as
well as the acquisition of HIV (Taha et al., 1998). Recent stud-
ies also indicate that the abnormal vaginal microbiome during
BV affects the natural history of cervical human papillomavirus
(HPV) and the development of cervical intraepithelial neoplasia
(CIN) (Rodriguez-Cerdeira et al., 2012; Gao et al., 2013; Wheeler,
2013). Such observations indicate a dynamic relationship between
the vaginal microbiome and the host; colonization by “normal”
microbiomes may protect by preventing colonization by poten-
tial pathogens or by creating conditions that do not favor survival
of the latter (Brotman et al., 2013). By disrupting this equilib-
rium, abnormal microbiomes create an environment that favors
infection or colonization by various pathogens.
NORMAL AND BV-ASSOCIATED VAGINAL MICROBIOMES
Advances in high-throughput sequencing have recently permitted
the development of culture-independent methods to determine
the composition of vaginal microbial communities (Ravel et al.,
2011). They have also permitted the evaluation of the effect of
various perturbations such as antibiotics, contraceptives and sex-
ual activity on this microbiome (Gajer et al., 2012; Brotman et al.,
2013; Ravel et al., 2013). Further, the altered microbiomes present
in clinically defined conditions such as BV have been character-
ized (Ravel et al., 2011, 2013; Datcu et al., 2013). Cross-sectional
surveys using such culture-independent methods have revealed
the existence of several types of vaginal communities in nor-
mal, healthy, women with distinct bacterial species compositions
(Ravel et al., 2011; Ma et al., 2012; Brotman et al., 2013). Four
of these communities are dominated by Lactobacillus species:
Type I—L. crispatus; Type II—L. gasseri; Type III—L. iners; and
Type V—L. jensenii. The fifth community type, labeled Type IV,
is dominated by facultative and strict anaerobes combined with
insignificant numbers of lactobacilli. The Type IV community
type is most closely associated with BV, as defined by a Nugent
score of 7–10. A study examining the cervical microbiome has
largely recapitulated the vaginal findings (Smith et al., 2012).
EFFECTS OF THE VAGINAL MICROBIOME ON
C. TRACHOMATIS
Several studies indicate the vaginal microbiome can influence C.
trachomatis infection. For example, pregnant women with flora
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in which H2O2-positive Lactobacillus spp. predominate are less
likely to be infected by C. trachomatis (Hillier et al., 1992). In con-
trast, studies using an American cohort, aged 15–30, indicated
a strong correlation between BV, as defined by Nugent scores
ranging from 7–10, and Chlamydia infection (odds ratio 3.4)
(Wiesenfeld et al., 2003). These results were recapitulated in stud-
ies examining a Japanese cohort of similarly aged women. The
latter studies found an association between BV (NS 7–10) and
Chlamydia infection with an odds ratio of 3.5 (Yoshimura et al.,
2009).
Differences between the normal and BV microbiome could
influence the normal development of Chlamydia, and the effect
of IFNγ on normal development in multiple ways. First, we
know that some members of the BV microbiome can express
a functional tryptophanase to produce indole from tryptophan
(Sasaki-Imamura et al., 2011), thus providing genital serovars of
C. trachomatis with a means to obtain tryptophan via indole sal-
vage. We also know from our recent studies that indole is present
in the vaginal secretions of patients with BV (Lewis et al., 2014).
Therefore, BV microbiome-produced indole could ameliorate
the effect of IFNγ-induced tryptophan depletion on Chlamydia
development. Indeed, tryptophan synthesis through indole sal-
vage is likely to be desirable for C. trachomatis for several reasons.
First, under hypoxic conditions, IDO1 can catabolize tryptophan
but not indole. Second, IDO1-mediated catabolism depletes tryp-
tophan levels within the chlamydial inclusion by decreasing extra-
cellular and cytoplasmic tryptophan, and not by directly acting
upon tryptophan within the inclusion. Third, mammalian cells
lack a tryptophan synthase activity; therefore, tryptophan biosyn-
thesis through indole salvage occurs solely within the chlamydial
inclusion, providing only the bacterium with this essential amino
acid with no competition from the host cell. Finally, because
IDO1 catabolizes only extracellular and cytoplasmic tryptophan,
it will not affect tryptophan synthesized within the inclusion.
The BV microbiome might also limit the effect of IFNγ on C.
trachomatis by other mechanisms. The Lactobacillus sp. that pre-
dominate in vaginal microbiome types I, II, III, and V do not syn-
thesize indole. In addition, they create a highly acidic H2O2-rich
environment (pH < 4.2) that is also not conducive to chlamy-
dial growth and development (Das et al., 2005; Haggerty et al.,
2009). In contrast, anaerobes present during BV (vaginal micro-
biome type IV) raise the pH to>4.6 and simultaneously produce
a hypoxic microenvironment. It is pertinent to note that the nor-
mal vaginal pH ranges from 3.8 to 4.5. Chlamydial re-infection is
favored at higher pH, and hypoxia reduces the restrictive effect of
IFNγ on chlamydial growth in two ways: (1) Low oxygen partial
pressure conditions (pO2) limit both IFNγ-dependent signaling
pathways (Roth et al., 2010); and (2) The enzymatic capacity of
IDO1 to catabolize tryptophan by dioxygenation is significantly
hampered by low pO2(Herbert et al., 2011).
POSSIBLE SOURCES OF INDOLE IN THE GENITAL TRACT
Although the normal and BV microbiomes display variations
between patients, there are several commonalities in their com-
position. The normal vagina (Nugent scores 0–3) contains ∼107
bacteria/10 ng of DNA recovered from vaginal swabs, in which
Lactobacillus spp. predominate. During BV (Nugent score 7–10),
the bacterial load is increased to ∼109 bacteria/10 ng DNA, in
which combinations of Prevotella spp. (>108/10 ng), Gardnerella
vaginalis (107/10 ng), Atopobium vaginae (105/10 ng), and/or
Megasphaera spp. (107/10 ng) become abundant. A large increase
in the fastidious bacterium of the order Clostridiales (BVAB1—
108/10 ng) is also observed. Lactobacillus spp. do not produce
indole, however many Prevotella spp. and strains can express a
tryptophanase (tnaA) to produce indole (Sasaki-Imamura et al.,
2011). Many sequenced members of the order Clostridiales also
encode a tryptophanase gene. BV infections are occasionally coin-
cident with infections by the protozoan pathogen Trichomonas
vaginalis that can also express a tryptophanase to produce indole
(Lloyd et al., 1991; Zubacova et al., 2011). Thus T. vaginalis co-
infections may represent another mechanism by which vaginal
co-infections impact the effect of IFNγ on C. trachomatis.
These results clearly indicate that indole-producing bacteria
are present within patients, with the levels of indole increas-
ing with higher Nugent scores. Several recent studies examining
the BV microbiome indicate that the increased representation of
Prevotella spp. is the strongest correlate of BV (NS 7–10) (Datcu
et al., 2013, 2014). Consistent with these, a metagenomic study
examining mRNA expressed by the BV microbiome indicated
that Prevotella spp. mRNA accounted for approximately 30% of
all the mRNA expressed by the BV microbiome (Twin et al.,
2013). The high representation of Prevotella spp. mRNA, cou-
pled with the observation that some oral strains of Prevotella can
express a tryptophanase, led us to test whether genital isolates
of Prevotella from BV patients could also synthesize indole. For
this, residual speculum fluid from three BV patients was used to
isolate anaerobes using laked blood agar kanamycin/vancomycin
media. Kanamycin/vancomycin-resistant constitutive anaerobes
were isolated from all three samples and tested for indole pro-
duction. Multiple isolates from two patients produced indole
robustly, while only a single isolate from the third patient
did. Partial 16S rRNA sequences (GenBank accession num-
bers KJ435311—KJ435324) confirmed all but one of the iso-
lates (indole producing and non-producing) to be Prevotella
spp. These results indicate that indole-producing bacteria can be
found in the microbiome from the female genital tract. Further,
there are variations between patients, such that even within the
same genus (i.e., Prevotella), genetic differences between isolates
can alter indole availability in a patient-specific manner.
A GENERAL ROLE FOR INDOLE AVAILABILITY IN THE
GENITAL TRACT
Genomic and functional analyses of other bacteria indicate
that indole is available in the genital tract. For example, while
environmental and nosocomial infection-associated isolates of
Staphylococcus aureus retain the capacity to synthesize tryptophan
de novo from chorismic acid, 80% of the Toxic Shock Syndrome
Toxin (TSST) producing S. aureus isolates have lost this capacity,
typically due to a deletion within the trpD gene (McGavin et al.,
2012). However, these TSS-associated isolates continue to encode
a functional tryptophan synthase, suggesting that indole and/or
IGP is likely available within the genital microenvironment,
permitting bacterial growth even during tryptophan starvation
(ibid).
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Similarly, several members of the normal and BV microbiome
can synthesize tryptophan de novo from chorismic acid, others,
such as G. vaginalis, resemble CT, in that they can only synthe-
size tryptophan by indole salvage. An analysis of the Gardnerella
vaginalis reference genome (GenBank accession NC_013721)
indicates it encodes a TrpB subunit that is 54% identical to the
TrpB subunit from Escherichia coli, with no additional domains.
However, no sequenced isolate ofG. vaginalis encodes a TrpA sub-
unit, implying that akin to CT, Gardnerella can use indole, but
not IGP, in the environment to synthesize tryptophan. Therefore,
it is likely that during tryptophan starvation, C. trachomatis
and Gardnerella both rely on indole produced by tryptophan
autotrophs that also encode a tryptophanase. For this reason,
the development and use of small molecule therapeutics that
target tryptophanase will not only promote IFNγ-mediated C.
trachomatis clearance, but also aid in the clearance of indole-
dependent BV bacteria such as G. vaginalis.
CONCLUDING REMARKS
In this review, we have described the mechanism by which IFNγ
could act as a protective cytokine against chlamydial infections.
IFNγ’s protective effects result from catabolism of the essential
amino-acid tryptophan by the enzyme IDO1. Depletion of tryp-
tophan can induce a viable but not cultivable persistent growth
phenotype in Chlamydia that can be reactivated when the IFNγ-
response wanes and/or tryptophan is made available in the envi-
ronment. Consistent with this, IFNγ exposure induces a chlamy-
dial pattern of gene expression that causes an up-regulation of
genes that can synthesize tryptophan through indole salvage and a
down-regulation of genes necessary for later stages of the chlamy-
dial normal development cycle. Genomic analyses indicate that a
selective pressure to maintain tryptophan synthesis via indole sal-
vage has been applied strictly to every genital Chlamydia serovar.
In contrast, no ocular serovars can salvage indole. Given that
the genes necessary for indole salvage (trpBA) are present in a
genetic plasticity zone, it is likely that indole availability in the
infectionmicroenvironment has been the selective factor tomain-
tain the capacity to salvage indole. Consistent with this, we have
found indole in vaginal secretions from patients that have BV,
and have isolated indole-producing bacteria from patients that
have BV. Therefore, it is likely that natural immunity against
chlamydial infections driven by a protective IFNγ response will
be attenuated in patients that have BV, dependent on the bacte-
rial representation within individual patients. For these reasons,
further studies that examine the correlates between spontaneous
clearance of chlamydial infections, the host cytokine response,
the host microbiome, and metabolites such as indole, are essen-
tial for the successful development of a protective vaccine against
Chlamydia. Further, understanding the nature and contribution
of BV-associated bacteria and their indole-producing capacity
and how this relates to the effectiveness of an IFNγ-mediated
resolution of C. trachomatis infection may also guide the man-
agement of BV in C. trachomatis-infected patients in the future.
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